title: The Cambridge model: how public oversight of biotech is good for everyone--even business.
authors.affiliation: Cambridge Public Health Department, USA.
authors.forename: Sam
authors.initials: S
authors.lastname: Lipson
mesh_terms: D026683:Advisory Committees; D001709:Biotechnology / Q000331:legislation & jurisprudence; D003256:Community Participation; D003159:Community-Institutional Relations; D003264:Containment of Biohazards; D004274:DNA, Recombinant; D005818:Genetic Engineering / Q000941:ethics / Q000331:legislation & jurisprudence; D036281:Genetic Research / Q000941:ethics* / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D017408:Guidelines as Topic; D006801:Humans; D007221:Industry / Q000331:legislation & jurisprudence*; D009111:Local Government; D008404:Massachusetts; D009316:National Institutes of Health (U.S.) / Q000592:standards; D011634:Public Health; D014481:United States
chemical_list: D004274:DNA, Recombinant